World's Best Scientists 2026 revealed!
david i smith

david i smith

D-Index & Metrics

Genetics

D-Index
84
Citations
20112
World Ranking
1376
National Ranking
649

Medicine

D-Index
86
Citations
21513
World Ranking
14303
National Ranking
7231

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Cancer

His primary scientific interests are in Cancer research, Genetics, Chromosomal fragile site, Carcinogenesis and Gene. His studies deal with areas such as Mutation, Transfection, Lymphoma, Tumor suppressor gene and Virus Integration as well as Cancer research. His studies in Tumor suppressor gene integrate themes in fields like Lung cancer, AXIN2, Colorectal cancer and Exon.

His Chromosomal fragile site research includes themes of Fluorescence in situ hybridization, Aphidicolin, Cervical cancer and Genome instability. His work deals with themes such as Molecular biology and Virology, which intersect with Carcinogenesis. The study incorporates disciplines such as Bladder cancer and Urinary bladder in addition to Molecular biology.

His most cited work include:

  • Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. (431 citations)
  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss (270 citations)
  • A role for common fragile site induction in amplification of human oncogenes. (251 citations)

What are the main themes of his work throughout his whole career to date?

David I. Smith spends much of his time researching Genetics, Cancer research, Gene, Chromosomal fragile site and Molecular biology. His Cancer research research includes elements of Carcinogenesis, Cancer, Tumor suppressor gene, Cell and Mutation. His Cancer research is multidisciplinary, relying on both Carcinoma, Pathology and Oncology.

His Chromosomal fragile site study also includes fields such as

  • FHIT which intersects with area such as WWOX,
  • Fluorescence in situ hybridization which intersects with area such as Bacterial artificial chromosome. He interconnects Translocation Breakpoint, Messenger RNA and Gene mapping in the investigation of issues within Molecular biology. His study looks at the relationship between Loss of heterozygosity and topics such as Ovarian cancer, which overlap with Ovary.

He most often published in these fields:

  • Genetics (40.96%)
  • Cancer research (40.43%)
  • Gene (36.17%)

What were the highlights of his more recent work (between 2009-2020)?

  • Genetics (40.96%)
  • Cancer research (40.43%)
  • Gene (36.17%)

In recent papers he was focusing on the following fields of study:

His main research concerns Genetics, Cancer research, Gene, Cancer and DNA sequencing. His studies deal with areas such as Cell, Gene expression profiling, Transcriptome, microRNA and Lymphoma as well as Cancer research. His study on Chromosomal fragile site, RNA, Sequence analysis and Fusion gene is often connected to TP63 as part of broader study in Gene.

His Cancer study integrates concerns from other disciplines, such as Oncology and Untranslated region. His studies in DNA sequencing integrate themes in fields like Genome, Human genome, Genomics and Computational biology. His Human genome research is multidisciplinary, incorporating elements of Cervical cancer, Whole genome sequencing and Molecular biology.

Between 2009 and 2020, his most popular works were:

  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss (270 citations)
  • Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. (198 citations)
  • Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas (145 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

David I. Smith mainly investigates Genetics, Gene, Cancer research, Chromosomal fragile site and Exome sequencing. His research combines Cervical adenocarcinoma and Gene. David I. Smith combines subjects such as Gene expression profiling, Cervical cancer, Lymphoma, Pathology and microRNA with his study of Cancer research.

He works on Chromosomal fragile site which deals in particular with Chromosome Fragile Site. David I. Smith has included themes like Hereditary sensory and autonomic neuropathy, Cell cycle phase, DNA mismatch repair and Hereditary motor and sensory neuropathy in his Exome sequencing study. The concepts of his RNA study are interwoven with issues in Molecular biology and Gene knockdown.

Best Publications

  • Role for the p53 homologue p73 in E2F-1-induced apoptosis

    Meredith Irwin;Maria Carmen Marin;Andrew C. Phillips;Ratnam S. Seelan

  • Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

    Liu W;Dong X;Mai M;Seelan Rs

  • Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

    Haojie Huang;Kevin M. Regan;Fang Wang;Diping Wang

  • Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

    Ken Taniguchi;Lewis R Roberts;Ileana N Aderca;Xiangyang Dong

  • Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

    Karen H. Lu;Andrea P. Patterson;Lin Wang;Rebecca T. Marquez

  • Malignant pheochromocytoma: Current status and initiatives for future progress

    Graeme Eisenhofer;Stefan R. Bornstein;Frederieke M. Brouwers;Nai Kong V. Cheung

  • MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons

    Penka S. Petrova;Andrei Raibekas;Jonathan Pevsner;Noel Vigo

  • Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss

    Christopher J. Klein;Maria Victoria Botuyan;Yanhong Wu;Christopher J. Ward

  • Mutations in CHEK2 associated with prostate cancer risk.

    Xiangyang Dong;Liang Wang;Ken Taniguchi;Xianshu Wang

  • Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations

    Wanguo Liu;David I. Smith;Keri J. Rechtzigel;Stephen N. Thibodeau

  • Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state.

    Horacio Murillo;Haojie Huang;Lucy J. Schmidt;David I. Smith

  • Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

    Rebecca T. Marquez;Keith A. Baggerly;Andrea P. Patterson;Jinsong Liu

  • A role for common fragile site induction in amplification of human oncogenes.

    Asaf Hellman;Eitan Zlotorynski;Stephen W Scherer;Joseph Cheung

  • Common fragile sites are preferential targets for HPV16 integrations in cervical tumors

    Erik C Thorland;Shannon L Myers;Bobbie S Gostout;David I Smith

  • Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

    Andrew L. Feldman;Ahmet Dogan;David I. Smith;Mark E. Law

  • Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.

    M J Ferber;D P Montoya;C Yu;I Aderca

  • Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.

    Jinping Lai;Jeremy Chien;Julie K. Staub;Rajeswari Avula

  • Genetic Analysis of Early- versus Late-Stage Ovarian Tumors

    Viji Shridhar;Ajay Pandita;Rajeswari Avula;Julie Staub

  • Long, abundantly expressed non-coding transcripts are altered in cancer

    Damon S. Perez;Tiffany R. Hoage;Jay R. Pritchett;Allison L. Ducharme-Smith

  • Replication of a Common Fragile Site, FRA3B, Occurs Late in S Phase and is Delayed Further Upon Induction: Implications for the Mechanism of Fragile Site Induction

    Michelle M. Le Beau;Feyruz V. Rassool;Mary E. Neilly;Rafael Espinosa

Frequent Co-Authors

Lewis R. Roberts
Lewis R. Roberts Mayo Clinic
Lynn C. Hartmann
Lynn C. Hartmann Mayo Clinic
Kerry D. Olsen
Kerry D. Olsen Mayo Clinic
Haojie Huang
Haojie Huang Mayo Clinic
Jeremy Chien
Jeremy Chien University of California, Davis
Bruce W. Eckloff
Bruce W. Eckloff Mayo Clinic
Yan W. Asmann
Yan W. Asmann Mayo Clinic
George Vasmatzis
George Vasmatzis Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics can open doors to a variety of healthcare and research careers. Many students interested in genetics also pursue nursing and advanced clinical roles, and online degrees are making this progression more accessible than ever.

Aspiring nurse practitioners can benefit from online nurse practitioner programs that offer flexibility and affordability. Those aiming to accelerate their careers may consider cheapest accelerated nursing programs, which save both time and cost while providing high-quality education.

Advancing even further, there are specialized options like online dnp fnp programs for those interested in clinical leadership or advanced practice. Additionally, registered nurses can expand their qualifications through online rn to bsn programs, bridging the gap to baccalaureate credentials and opening more career opportunities in genetics, education, and research.

Exploring these online degree options allows students to tailor their career pathway in genetics and healthcare, matching educational goals with the evolving demands of the field.

Best Scientists Citing david i smith

Trending Scientists

Recently Published Articles